Correlation Between Viracta Therapeutics and Supernus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Supernus Pharmaceuticals, you can compare the effects of market volatilities on Viracta Therapeutics and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Supernus Pharmaceuticals.
Diversification Opportunities for Viracta Therapeutics and Supernus Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Viracta and Supernus is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Supernus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Supernus Pharmaceuticals
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Supernus Pharmaceuticals. In addition to that, Viracta Therapeutics is 1.53 times more volatile than Supernus Pharmaceuticals. It trades about -0.41 of its total potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest 3,416 in Supernus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 194.00 from holding Supernus Pharmaceuticals or generate 5.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Supernus Pharmaceuticals
Performance |
| Timeline |
| Viracta Therapeutics |
| Supernus Pharmaceuticals |
Viracta Therapeutics and Supernus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Supernus Pharmaceuticals
The main advantage of trading using opposite Viracta Therapeutics and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
| Supernus Pharmaceuticals vs. Prestige Brand Holdings | Supernus Pharmaceuticals vs. Evotec SE ADR | Supernus Pharmaceuticals vs. Collegium Pharmaceutical | Supernus Pharmaceuticals vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |